|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 11/02 | (2018.01) |
| A61M 11/00 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| C07K 16/00 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61M 15/0085 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61M 11/005 | (2013.01) | ||
| B05B 17/06 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61K 9/0078 | (2013.01) | ||
| C07K 16/10 | (2006.01) | ||
| A61P 37/02 | (2018.01) | ||
| C07K 16/12 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61M 11/001 | (2014.02) | ||
| C07K 16/1027 | (2013.01) | ||
| A61P 11/02 | (2006.01) | ||
| A61K 39/39591 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| C07K 16/1275 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| B05B 17/0646 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61M 15/00 | (2006.01) | ||
| B05B 17/00 | (2006.01) |
| (11) | Number of the document | 3125942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15715209.1 |
| Date of filing the European patent application | 2015-04-02 | |
| (97) | Date of publication of the European application | 2017-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/057285 |
| Date | 2015-04-02 |
| (87) | Number | WO 2015/150510 |
| Date | 2015-10-08 |
| (30) | Number | Date | Country code |
| 14163399 | 2014-04-03 | EP |
| (72) |
VONARBURG, Cédric Pierre , CH
STEINFÜHRER, Karin , DE
BAUMANN, Ulrich , DE
|
| (73) |
CSL Behring AG ,
Wankdorfstrasse 10, 3014 Bern,
CH
PARI Pharma GmbH , Moosstrasse 3, 82319 Starnberg, DE Medizinische Hochschule Hannover , Carl-Neuberg-Strasse 1, 30625 Hannover, DE |
| (54) | NEBULIZATION OF IMMUNOGLOBULIN |
| NEBULIZATION OF IMMUNOGLOBULIN |